Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesMolecular Fluorescent Imaging of Suspicious NevusCPT cpt-0700t-fluorescence-imaging-skin-lesion-assessment
    Ask Trek AI about this page

    CPT 0700T: Fluorescence Imaging for Suspicious Skin Lesion, First Lesion

    CPT code 0700T describes a diagnostic procedure using a fluorescent dye, a specialized imaging device, and analysis software to assess a suspicious mole (first lesion) for tissue changes and cellular abnormalities; this is an imaging-based dermatologic diagnostic service typically performed in an outpatient dermatology clinic or procedure room and is classified as a lesion-targeted diagnostic imaging service for suspicious skin lesions.

    For related coverage guidance, see recent payer policy updates: Mohs Micrographic Surgery, Mohs Micrographic Surgery, Mohs Micrographic Surgery.

    Customize your policy alerts

    Sign up for cpt 0700T policy alerts

    Get alerted when payer policies referencing 0700T are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A 58-year-old patient presents to a dermatology clinic with a solitary pigmented lesion that has recently changed in color and outline. The clinician performs an in‑office optical assessment using a topical fluorescent dye, a dedicated fluorescence imaging device, and analysis software to evaluate cellular and structural abnormalities within the first suspicious lesion. The workflow includes: pre-procedure informed consent, application of the fluorescent agent to the lesion, image capture with the device, automated and clinician review of software-generated analysis, documentation of findings in the medical record, and determination of next steps (serial monitoring, biopsy, or excision). Typical site of service is an outpatient dermatology clinic or ambulatory surgical center. The service is provided by dermatologists or dermatologic surgeons trained in the fluorescence imaging system and by dermatology physician assistants or nurse practitioners under their supervision. Typical clinical indications include newly changing pigmented lesions, lesions with clinical/dermoscopic concern for malignancy, or lesions in patients with a history of melanoma under surveillance.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    11102Tangential biopsy of skin (eg, shave, scoop), single lesion; first lesionPerformed after imaging when the clinician decides tissue diagnosis is indicated for the suspicious lesion evaluated by 0700T.
    11100Biopsy of skin, subcutaneous tissue and/or mucous membrane (eg, shave, punch), single lesionAlternative minor biopsy technique used to obtain tissue after imaging suggests abnormality.
    11305Shave biopsy of skin lesion, trunk, arms or legs; single lesion, moderate to largeUsed when a larger shave specimen is clinically required following imaging evaluation.
    88305Level IV surgical pathology, gross and microscopic examinationUsed for histopathologic evaluation of biopsy specimens obtained after fluorescence imaging indicates need for tissue diagnosis.
    17000Destruction (eg, laser surgery, electrosurgery, cryosurgery), premalignant lesion (e.g., actinic keratosis); first lesionMay be used when imaging suggests a benign premalignant lesion where destruction is the chosen therapy rather than biopsy.

    Related Modifiers

    6 rows

    ModifierDescriptionWhen to Use
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207N00000X
    163W00000X
    363A00000X
    246RM2200X
    2355S0801X
    261QP0904X
    372500000X
    207SM0001X

    Related ICD-10-CM Codes

    27 rows

    ICD-10-CM CodeDescription
    B07.9Viral wart, unspecified
    B35.0Tinea barbae and tinea capitis
    C43.9Malignant melanoma of skin, unspecified
    C44.91Basal cell carcinoma of skin, unspecified
    C44.92Squamous cell carcinoma of skin, unspecified
    D03.9Melanoma in situ, unspecified
    D04.9Carcinoma in situ of skin, unspecified
    D22.9Melanocytic nevi, unspecified
    L13.9Bullous disorder, unspecified
    L57.0Actinic keratosis

    Showing 1–10 of 27

    Related Payer Policy Updates

    Specialty: Dermatology1 / 3

    10 rows

    PolicyPayerEffective Date
    Mohs Micrographic Surgerypremerabluecrossofwashington2027-02-05
    Mohs Micrographic Surgerypremerabluecrossofwashington2027-02-05
    Mohs Micrographic Surgerypremerabluecrossofwashington2027-02-05
    Opzelura (ruxolitinib 1.5% cream) Coverage PolicyCigna2026-11-15
    FilsuvezCigna2026-11-01
    Destruction of Pre-Malignant Skin LesionsAnthem2026-10-01
    Onychomycosis diagnostic testing and coverageOscar Health2026-10-01
    Treatment of Capillary Malformations (Port Wine Stains)universityofutahhealthplans2026-09-28
    AnzupgoCigna2026-09-15
    Chemical Peelsregence2026-09-01

    Related Codes

    CPT-0701T-FLUORESCENCE-IMAGING-ADDITIONAL-LESION-ASSESSMENT

    CPT 0701T: Fluorescent Imaging for Additional Suspicious Skin Lesion

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.